Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D
Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00115-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/...